Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ensign GroupENSG -0.02%91 EV-to-EBITDA is 20.23 as of Aug. 20, 2026, which is 9% above its 10-year median of 18.59. GuruFocus rates ENSG with a GF Score™ of 91/100 and a GF Value™ of $183.09 (Fairly Valued). The stock has 3 warning signs investors should review. Among 513 Healthcare Providers & Services companies, Ensign Group ranks worse than 76.22% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ensign Group's enterprise value is $12,569 Mil.
Ensign Group's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was $621 Mil. Therefore, Ensign Group's EV-to-EBITDA for today is 20.23.
The historical rank and industry rank for Ensign Group's EV-to-EBITDA or its related term are showing as below:
ENSG'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.1 Med: 18.59 Max: 34.77
Current: 20.23
During the past 13 years, the highest EV-to-EBITDA of Ensign Group was 34.77. The lowest was 8.10. And the median was 18.59.
ENSG's EV-to-EBITDA is ranked worse than 76.22% of 513
companies
in the Healthcare Providers & Services industry
Industry Median: 10.76
vs ENSG: 20.23
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ensign Group's PE Ratio (TTM) for today is calculated as:
Ensign Group's share price for today is $182.49.
Ensign Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.380.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Ensign Group's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Ensign Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ensign Group EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ensign Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Ensign Group's EV-to-EBITDA falls into.
Ensign Group's current Enterprise Value is $12,569 Mil.
Ensign Group's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $621 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ensign Group (ENSG) has a EV-to-EBITDA of 20.23 as of Aug. 20, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Ensign Group. This is near median its historical median of 18.59. Over the past decade, Ensign Group's EV-to-EBITDA has ranged from 8.10 to 34.77. According to the industry distribution chart, Ensign Group ranks #391 out of 513 companies in the Healthcare Providers & Services industry, placing it in the top 76.2%.
Is Ensign Group's EV-to-EBITDA too high?
Ensign Group's current EV-to-EBITDA of 20.23 is near median its 10-year median of 18.59. Over the past 10 years, this metric has ranged from a low of 8.10 to a high of 34.77. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.76. Ensign Group's value of 20.23 is 88% above this industry median. Based on the distribution chart, Ensign Group ranks #391 out of 513 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Ensign Group has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ensign Group's EV-to-EBITDA compare to UHS and EHC?
According to the Healthcare Providers & Services industry distribution chart, Ensign Group ranks #391 out of 513 companies for EV-to-EBITDA. This places Ensign Group in the lower half of its industry. The industry median EV-to-EBITDA is 10.76. Ensign Group's value of 20.23 is 88% above this benchmark. Historically, Ensign Group's own EV-to-EBITDA has ranged from 8.10 to 34.77 over the past decade. While the company's 10-year median is 18.59 vs. the industry median of 10.76, Ensign Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.76, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ensign Group's current EV-to-EBITDA of 20.23 is 88% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Ensign Group. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ensign Group's current EV-to-EBITDA is 20.23, which is near median its own 10-year median of 18.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ensign Group stock overvalued right now?
Based on GuruFocus' analysis, Ensign Group (ENSG) is currently considered Fairly Valued. The stock's GF Value™ is $183.09, compared to a current price of $182.49 — trading 0.3% below its estimated fair value. The current EV-to-EBITDA is 20.23, which is near median its 10-year median of 18.59 and 88% above the Healthcare Providers & Services industry median of 10.76. Ensign Group's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Ensign Group (ENSG), the current EV-to-EBITDA is 20.23 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ensign Group (ENSG) Overvalued in 2026?
Based on GuruFocus' analysis, Ensign Group stock appears to be undervalued.
The current stock price of $182.49 is trading 0.3% below its estimated GF Value™ of $183.09.
GuruFocus considers Ensign Group to be Fairly Valued.
Key valuation signals for ENSG:
EV-to-EBITDA: 20.23 (near median its 10-year median of 18.59)
GF Value™: $183.09 vs. price of $182.49 (0.3% below fair value)
Industry Position: 88% above the Healthcare Providers & Services median (#391 of 513)
No single metric tells the full story. See the ENSG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The Standard Bearer segment comprises of properties owned by the company through its captive REIT and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the skilled services segment.
91GF Score
Get the complete analysis for ENSG
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ENSG has been successfully added to your 
